Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ma BBY et al. – This study suggests that most NPC cell lines are intrinsically resistant to gefitinib (except HK1 cells), and further studies are needed to confirm whether EGFR gene amplification and persistent AKT activation may influence response to gefitinib in NPC.

Related Articles

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
European Archives of Oto-Rhino-Laryngology, 10/14/09    Relevance Score: 68%

Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review
The Journal of Laryngology & Otology, 10/06/09    Relevance Score: 68%

Horner Syndrome as a Presenting Sign of Nasopharyngeal Carcinoma
Ophthalmic Plastic and Reconstructive Surgery, 10/07/09    Relevance Score: 67%

Widespread expression of prostate apoptosis response-4 in nasopharyngeal carcinoma
Head & Neck, 11/13/09    Relevance Score: 66%

Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth
Head & Neck, 10/16/09    Relevance Score: 65%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address